Singapore Drug Registration and DMFs for APIs, Excipients & Packaging Materials
Utilize our intimate industry knowledge and expertise to obtain Singapore HSA registration approval for your drug.
To learn more about how PBM can help you register your drug products in Singapore, please contact us.
The Singaporean regulator of pharmaceuticals is the Health Sciences Authority (HSA). The Therapeutic Products Division of the HSA is accountable for reviewing and approving pharmaceuticals; their subdivision is the Pharmaceuticals & Biologics Branch.
All drugs require a product license prior to being imported or sold in Singapore. When applying for a product license, dossiers must comply with the International Conference on Harmonisation (ICH) Common Technical Document (CTD) format or the ASEAN Common Technical Document (ACTD) format.
For new product licenses, Singapore requires a new drug application (NDA) and a generic drug application (GDA). For products previously approved by certain regulatory agencies (e.g. Australia’s TGA, US FDA, etc.), submitting an abridged dossier is a possible option. Applicants submit an online application and CTD dossier through PRISM (Pharmaceutical Regulatory and Information System).
To learn more about how PBM can help you register your drug products in Singapore, please contact us.
Related Resources
Visit our Resource Center to view free webcasts and charts or read publications, news, and research reports on the Asia medical markets.
Related News Briefs
Visit our Resource Center to view free webcasts and charts or read publications, news, and research reports on the Asia medical markets.